These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 761440)

  • 1. Guanfacine kinetics in patients with hypertension.
    Weiss YA; Lavene DL; Safar ME; Simon AC; Loria Y; Georges DR; Milliez PL
    Clin Pharmacol Ther; 1979 Mar; 25(3):283-93. PubMed ID: 761440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical pharmacology of the antihypertensive action of guanfacine].
    Safar M; Weiss Y; Georges D
    Arch Mal Coeur Vaiss; 1980 Oct; 73(10):1171-7. PubMed ID: 6778409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent blood pressure effects of guanfacine.
    Frisk-Holmberg M; Wibell L
    Clin Pharmacol Ther; 1986 Feb; 39(2):169-72. PubMed ID: 2867846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of renal function on plasma concentration, urinary excretion and antihypertensive effect of guanfacine.
    Kirch W; Köhler H; Braun W; von Gizycki C
    Clin Pharmacokinet; 1980; 5(5):476-83. PubMed ID: 6996890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elimination of guanfacine in patients with normal and impaired renal function.
    Kirch W; Köhler H; Braun W
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):33S-35S. PubMed ID: 6994776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bioavailability and pharmacokinetics of guanfacine after oral and intravenous administration to healthy volunteers.
    Carchman SH; Crowe JT; Wright GJ
    J Clin Pharmacol; 1987 Oct; 27(10):762-7. PubMed ID: 3323255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of guanfacine in patients with impaired renal function and in some elderly patients.
    Kiechel JR
    Am J Cardiol; 1986 Mar; 57(9):18E-21E. PubMed ID: 3513525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic study of guanfacine in patients with renal insufficiency and in patients under chronic dialysis (author's transl)].
    Kiechel JR; Lavene D; Gurret M; Coustenoble J; Petrover M; Godin M; Fillastre JP
    Nephrologie; 1980; 1(2):73-81. PubMed ID: 7029332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Small and large doses of guanfacine (Estulic Sandoz) in the treatment of hypertension.
    Mayer O; Polívková H
    Cor Vasa; 1987; 29(4 Suppl 1):37-41. PubMed ID: 3315449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanfacine for hypertension.
    Med Lett Drugs Ther; 1987 May; 29(740):49-50. PubMed ID: 2883560
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacokinetics and metabolism of guanfacine in man: a review.
    Kiechel JR
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):25S-32S. PubMed ID: 6994775
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of once-daily guanfacine and twice-a-day methyldopa in the treatment of mild to moderate hypertension.
    Farooki MS; Farsky K; Bouchard S; Lalonde Y; Brookman S
    Clin Ther; 1985; 7(2):199-204. PubMed ID: 3886142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of estulic [corrected] in humans.
    Cherruault Y; Sarin VB
    Int J Biomed Comput; 1986 Mar; 18(2):123-30. PubMed ID: 3516889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Minimal useful dose of guanfacine in patients with essential hypertension].
    Pérez Olea J; Ortíz N; Soledad Bertoló M; Allel L; Goity C; Quevedo M
    Rev Med Chil; 1985 May; 113(5):420-4. PubMed ID: 3912882
    [No Abstract]   [Full Text] [Related]  

  • 15. Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension.
    Sorkin EM; Heel RC
    Drugs; 1986 Apr; 31(4):301-36. PubMed ID: 3519177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of arterial hypertension with a single daily dose of guanfacine].
    Jardim PC; Rassi S; Lopes M; Simioni PR; Guimarães E; Maranhão MF; Porto CC
    Arq Bras Cardiol; 1984 Nov; 43(5):365-9. PubMed ID: 6399438
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I; Skultétyová D; Mikulecký M; Kratochvíl'ová H
    Cor Vasa; 1987; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Labetalol and guanfacine in the treatment of arterial hypertension in patients with chronic renal failure].
    Lifshits NL; Ermolenko VM; Rozhdestvenskaia TM; Tatsievskiĭ VA; Panasiuk VV
    Ter Arkh; 1984; 56(7):66-9. PubMed ID: 6385325
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of the hypotensive drug guanfacine in the treatment of patients with hypertension].
    Kravchenko IG; Liashenko MM; Tarnakin AG; Chirkov SN
    Kardiologiia; 1986 Mar; 26(3):41-5. PubMed ID: 3520085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of guanfacine in patients undergoing haemodialysis.
    Kirch W; Kohler H; Axthelm T
    Eur J Drug Metab Pharmacokinet; 1982; 7(4):277-80. PubMed ID: 6762301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.